Impact of Data on Generalized Pustular Psoriasis
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Study Limitations in Generalized Pustular Psoriasis
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss study limitations regarding health records in generalized pustular psoriasis and how the number of flares could be underestimated.
Importance of Understanding Data of Generalized Pustular Psoriasis Data
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss the importance of investigating the data on generalized pustular psoriasis, comorbidities of the disease, and commonly used treatments.
Current Treatments for Generalized Pustular Psoriasis
Experts in dermatology review data on various treatment interventions before, during, and after generalized pustular psoriasis flare episodes.
Study Results for Patients With Generalized Pustular Psoriasis
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, examine the results of a study of generalized pustular psoriasis, discussing flares and common signs and symptoms.
Baseline Characteristics of Patients With Generalized Pustular Psoriasis
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, review the demographics of people with generalized pustular psoriasis including age, race, and comorbidities.
Understanding Flares in Patients With GPP Documented in US Electronic Health Records
Expert dermatologists discuss the methods of a study of US health records of patients with generalized pustular psoriasis.
Overview of Generalized Pustular Psoriasis (GPP)
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, provide an overview of generalized pustular psoriasis, identifying flares, the burden on patients, and available treatment options.
One test helps inform two key clinical decisions in the management of melanoma
